Medtronic (MDT): Polar Asset Management Partners Inc. added to its stake +336K shares
Polar Asset Management Partners Inc. added to its stake in Medtronic, per its Q1 2025 13F.
- 483K
- Shares reported · +336K vs prior quarter
- 1.2%
- Disclosed portfolio weight
- $43.4M
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- May 15, 2025
What stands out in this filing
- 146,800 shares in Q4 2024, 482,632 now (+228.8% in share count).
- Reported at $43.4M, 1.24% of the portfolio value in this 13F filing.
- 70 other tracked managers reported the same kind of change for Q1 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 25, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Mar 4, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Mar 20, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Mar 24, 2025CongressDisclosed sale of MDT — reported range $50,001 - $100,000
- Apr 8, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- May 8, 2025CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- May 15, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
What came next
- Jun 18, 2025FDARecall: Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Cobalt Crome application, Software Model Number D…
- Jun 18, 2025FDARecall: Medtronic CareLink SmartSync Device Manager, Model Number 24967A with the following software components: 1. Cobalt Crome application, Software Model Number D00…
- Jun 20, 2025FDAFDA device clearance: MC2 Two-Stage Venous Cannula; MC2X Three-Stage Venous Cannula
- Jun 23, 2025FDARecall: Covidien Nellcor Bedside SpO2 Patient Monitoring System: REF: PM100N, 10005941, DLPM100N, DL10005941, DSPM100N, 10005941-SG, DS10005941, 10005941J, 10005941JP,…
- Jun 26, 2025FDAFDA device clearance: The Rialto SI Fusion System
- Jul 1, 2025FDAFDA device clearance: MiniMed 780G insulin pump
- Jul 17, 2025FDARecall: IPC Powerease System REF 2300000 UDI-DI: 00613994448705 00643169406834. The IPC POWEREASE System is indicated for drilling, tapping, and driving screws and wor…
- Aug 6, 2025FDAFDA device approval: Simplera Sync Sensor, Guardian 4 Sensor
- Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12110 LV VENT 10FR, Model Number 12110
- Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12115 LV VENT 15FR, Model Number 12115
- Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12113 LV VENT 13FR, Model Number 12113
- Aug 14, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Aug 22, 2025InsiderDirector purchased ~$232K of MDT shares in the open market
- Aug 25, 2025InsiderDirector purchased ~$231K of MDT shares in the open market
- Aug 29, 2025FDAFDA device clearance: SmartGuard technology; Predictive Low Glucose technology
- Sep 3, 2025Insider · 1 personInsiders: 2 sales (~$788K)
- Sep 4, 2025FDAFDA device clearance: Endoskeleton Interbody Systems
- Sep 11, 2025FDAFDA device clearance: Mazor X System / Mazor X Stealth Edition
- Sep 12, 2025FDARecall: Affinity NT Oxygenator, Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir, Product Number 541B
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
How this filing works
Explore the data
Common questions
What does this filing report about Medtronic (MDT) stock?
Polar Asset Management Partners Inc. added to its stake in Medtronic, per its Q1 2025 13F. Now 483K shares, $43.4M reported value, 1.2% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: May 15, 2025.
What stands out in this filing?
146,800 shares in Q4 2024, 482,632 now (+228.8% in share count). Reported at $43.4M, 1.24% of the portfolio value in this 13F filing. 70 other tracked managers reported the same kind of change for Q1 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Medtronic recently?
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.
Does this mean MDT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
